Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network.
Multicenter trials
Trial Innovation Network
clinical trial budgets
clinical trial resources
informative trials
study planning
Journal
Journal of clinical and translational science
ISSN: 2059-8661
Titre abrégé: J Clin Transl Sci
Pays: England
ID NLM: 101689953
Informations de publication
Date de publication:
2023
2023
Historique:
received:
31
01
2023
revised:
04
05
2023
accepted:
16
05
2023
medline:
3
7
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
epublish
Résumé
One challenge for multisite clinical trials is ensuring that the conditions of an informative trial are incorporated into all aspects of trial planning and execution. The multicenter model can provide the potential for a more informative environment, but it can also place a trial at risk of becoming uninformative due to lack of rigor, quality control, or effective recruitment, resulting in premature discontinuation and/or non-publication. Key factors that support informativeness are having the right team and resources during study planning and implementation and adequate funding to support performance activities. This communication draws on the experience of the National Center for Advancing Translational Science (NCATS) Trial Innovation Network (TIN) to develop approaches for enhancing the informativeness of clinical trials. We distilled this information into three principles: (1) assemble a diverse team, (2) leverage existing processes and systems, and (3) carefully consider budgets and contracts. The TIN, comprised of NCATS, three Trial Innovation Centers, a Recruitment Innovation Center, and 60+ CTSA Program hubs, provides resources to investigators who are proposing multicenter collaborations. In addition to sharing principles that support the informativeness of clinical trials, we highlight TIN-developed resources relevant for multicenter trial initiation and conduct.
Identifiants
pubmed: 37396815
doi: 10.1017/cts.2023.560
pii: S2059866123005605
pmc: PMC10308427
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e131Subventions
Organisme : NCATS NIH HHS
ID : U24 TR001597
Pays : United States
Organisme : NCATS NIH HHS
ID : U24 TR001609
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States
Informations de copyright
© The Author(s) 2023.
Déclaration de conflit d'intérêts
Co-Author, Daniel K. Benjamin, Jr., Duke Clinical Research Institute, reports consultancies with AbbieVie, PPD, and Syneos Health. No other authors have declared conflicts of interest or financial involvements that might potentially bias their work.
Références
Clin Transl Sci. 2017 Sep;10(5):311-313
pubmed: 28271602
Ther Innov Regul Sci. 2016 Jul;50(4):436-441
pubmed: 30227022
Elife. 2022 Aug 17;11:
pubmed: 35975784
Trials. 2010 Jul 13;11:78
pubmed: 20626885
J Am Med Inform Assoc. 2022 Mar 15;29(4):652-659
pubmed: 34850917
Eur Respir J. 2008 Nov;32(5):1141-3
pubmed: 18978131
JAMA. 2019 Sep 3;322(9):813-814
pubmed: 31343666
JAMA. 2014 Mar 12;311(10):1045-51
pubmed: 24618966
J Clin Transl Sci. 2018 Aug;2(4):187-192
pubmed: 31011433
Appl Clin Inform. 2018 Jan;9(1):72-81
pubmed: 29388180
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16385-9
pubmed: 15534225
Trials. 2016 Apr 26;17(1):212
pubmed: 27113592
J Gen Intern Med. 2021 Feb;36(2):533-536
pubmed: 32918201